SCHEMBL98073

SCHEMBL98073

NCCCCC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1959776 1.00 DNM1 (0.50)
SCHEMBL8811124 1.00 DNM1 (0.50)
SCHEMBL1960836 1.00 DNM1 (0.50)
SCHEMBL8812186 1.00 DNM1 (0.50)
SCHEMBL666946 1.00 DNM1 (0.50)
SCHEMBL381495 1.00 DNM1 (0.50)
SCHEMBL186389 1.00
SCHEMBL8812602 1.00 DNM1 (0.50)
SCHEMBL465588 1.00 DNM1 (0.50)
SCHEMBL8812125 1.00 DNM1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2766 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118354781-A Peptide inhibitors of interleukin-23 receptor 西兰制药公司 2024-07-16 CN claimed
WO-2024145507-A2 LIGASE AND DEHYDROGENASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2024-07-04 WO claimed
CN-118021978-A GHRH antagonists for use in methods of treating sarcoidosis 迈阿密大学 2024-05-14 CN claimed
US-11965039-B2 Compstatin analogues and their medical uses ZP SPV 3 K/S (DK) 2024-04-23 US claimed
EP-4331674-A2 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS University of Miami (US) 2024-03-06 EP claimed
EP-3442594-B1 BLOCK COPOLYMER FOR OVERCOMING DRUG RESISTANCE OF TUMOURS TO CHEMOTHERAPY, ITS POLYMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION CONTAINING THEM, METHOD OF PREPARATION AND USE THEREOF USTAV MAKROMOLEKULARNI CHEMIE AV CR V V I (CZ) 2024-02-07 EP claimed
CN-109906231-B Aptamer chimeric antigen receptor expressing cells for targeting multiple antigens 美天施生物科技有限两合公司 2023-12-26 CN claimed
EP-4284812-A1 NOVEL SELECTIVE ANTIMICROBIAL FUSION PEPTIDES Bombi Biomics BV (NL) 2023-12-06 EP claimed
EP-4272751-A2 COMPSTATIN ANALOGUES AND THEIR MEDICAL USES ZP SPV 3 K/S (DK) 2023-11-08 EP claimed
EP-3999095-B1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS UNIV MIAMI (US) 2023-09-13 EP claimed
EP-0334244-A2 Bradykinin Antagonist Peptides THE PROCTER & GAMBLE COMPANY (US) 1989-09-27 EP claimed
US-4855286-A HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-08 US claimed
EP-0303243-A2 Use of atrial natriuretic factor (ANF), fragments and analogues thereof, for the treatment of cardiac disorders HOECHST AKTIENGESELLSCHAFT (DE) 1989-02-15 EP claimed
EP-0299397-A2 Peptides with vasorelaxing, natriuretic and diuretic activities, preparation process, agents containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-18 EP claimed
EP-0255082-A2 Renin-inhibiting di- and tripeptides, methods for their production, drugs containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1988-02-03 EP claimed
EP-0239874-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their application HOECHST AKTIENGESELLSCHAFT (DE) 1987-10-07 EP claimed
EP-0231752-A2 Vasorelaxing, natriuretically and diuretically active peptides, process for their preparation, agents containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-08-12 EP claimed
EP-0230242-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-07-29 EP claimed
EP-0179332-A2 ZNS-active peptides acting on the cholinergetic system HOECHST AKTIENGESELLSCHAFT (DE) 1986-04-30 EP claimed
US-4066506-A METHOD OF SEPARATING AND PURIFYING TWO ACTIVE FORMS OF UROKINASE USING AFFINITY CHROMATOGRAPHY THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH, EDUCATION AND WELFARE (US) 1978-01-03 US claimed